These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 16400423

  • 21. A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease.
    Shinno H, Inagaki T, Miyaoka T, Okazaki S, Kawamukai T, Utani E, Inami Y, Horiguchi J.
    J Neurol Sci; 2007 Sep 15; 260(1-2):132-8. PubMed ID: 17540407
    [Abstract] [Full Text] [Related]

  • 22. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
    Suriyajakryuththana W, Tuntiyatorn L, Teepprasarn N, Sukying C.
    J Med Assoc Thai; 2014 Apr 15; 97(4):407-14. PubMed ID: 24964683
    [Abstract] [Full Text] [Related]

  • 23. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy.
    Lazeyras F, Charles HC, Tupler LA, Erickson R, Boyko OB, Krishnan KR.
    Psychiatry Res; 1998 May 20; 82(2):95-106. PubMed ID: 9754452
    [Abstract] [Full Text] [Related]

  • 24. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    Wang H, Tan L, Wang HF, Liu Y, Yin RH, Wang WY, Chang XL, Jiang T, Yu JT.
    J Alzheimers Dis; 2015 May 20; 46(4):1049-70. PubMed ID: 26402632
    [Abstract] [Full Text] [Related]

  • 25. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M, Melzer TR, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Wood KL, Keenan RJ, Dalrymple-Alford JC, Anderson TJ.
    Parkinsonism Relat Disord; 2016 Jan 20; 22():54-61. PubMed ID: 26627939
    [Abstract] [Full Text] [Related]

  • 26. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
    Huang W, Alexander GE, Chang L, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB.
    Neurology; 2001 Aug 28; 57(4):626-32. PubMed ID: 11524470
    [Abstract] [Full Text] [Related]

  • 27. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
    Zhu X, Schuff N, Kornak J, Soher B, Yaffe K, Kramer JH, Ezekiel F, Miller BL, Jagust WJ, Weiner MW.
    Alzheimer Dis Assoc Disord; 2006 Aug 28; 20(2):77-85. PubMed ID: 16772742
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease.
    Catani M, Mecocci P, Tarducci R, Howard R, Pelliccioli GP, Mariani E, Metastasio A, Benedetti C, Senin U, Cherubini A.
    J Am Geriatr Soc; 2002 Oct 28; 50(10):1707-10. PubMed ID: 12366626
    [Abstract] [Full Text] [Related]

  • 30. 1H MR spectroscopy in common dementias.
    Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, O'Brien PC, Weigand SD, Edland SD, Smith GE, Ivnik RJ, Ferman TJ, Tangalos EG, Jack CR.
    Neurology; 2004 Oct 26; 63(8):1393-8. PubMed ID: 15505154
    [Abstract] [Full Text] [Related]

  • 31. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Waragai M, Moriya M, Nojo T.
    J Alzheimers Dis; 2017 Oct 26; 60(4):1411-1427. PubMed ID: 28968236
    [Abstract] [Full Text] [Related]

  • 32. Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis.
    Tumati S, Martens S, Aleman A.
    Neurosci Biobehav Rev; 2013 Dec 26; 37(10 Pt 2):2571-86. PubMed ID: 23969177
    [Abstract] [Full Text] [Related]

  • 33. Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Rami L, Gómez-Ansón B, Bosch B, Sánchez-Valle R, Monte GC, Villar A, Molinuevo JL.
    Dement Geriatr Cogn Disord; 2007 Dec 26; 24(4):274-9. PubMed ID: 17717413
    [Abstract] [Full Text] [Related]

  • 34. Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
    Waragai M, Hata S, Suzuki T, Ishii R, Fujii C, Tokuda T, Arai H, Ohrui T, Higuchi S, Yoshida M, Igarashi K, Moriya M, Iwai N, Uemura K.
    J Alzheimers Dis; 2014 Dec 26; 41(4):1207-22. PubMed ID: 24787913
    [Abstract] [Full Text] [Related]

  • 35. Contribution of 1H spectroscopy to a brief cognitive-functional test battery for the diagnosis of mild Alzheimer's disease.
    Silveira de Souza A, de Oliveira-Souza R, Moll J, Tovar-Moll F, Andreiuolo PA, Bottino CM.
    Dement Geriatr Cogn Disord; 2011 Dec 26; 32(5):351-61. PubMed ID: 22311276
    [Abstract] [Full Text] [Related]

  • 36. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy.
    Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD.
    Radiology; 1993 May 26; 187(2):433-7. PubMed ID: 8475286
    [Abstract] [Full Text] [Related]

  • 37. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
    Martínez-Bisbal MC, Arana E, Martí-Bonmatí L, Martínez-Granados B, Celda B.
    Radiologia; 2006 May 26; 48(5):301-7. PubMed ID: 17168239
    [Abstract] [Full Text] [Related]

  • 38. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
    Walecki J, Barcikowska M, Ćwikła JB, Gabryelewicz T.
    Med Sci Monit; 2011 Dec 26; 17(12):MT105-11. PubMed ID: 22129910
    [Abstract] [Full Text] [Related]

  • 39. [Cerebral metabolism in patients with cognitive disorders: a combined MRS and PET study].
    Khomenko YG, Kataeva GV, Bogdan AA, Chernysheva EM, Susin DS.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019 Dec 26; 119(1):51-58. PubMed ID: 30778031
    [Abstract] [Full Text] [Related]

  • 40. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
    Watanabe T, Shiino A, Akiguchi I.
    Dement Geriatr Cogn Disord; 2008 Dec 26; 26(1):89-100. PubMed ID: 18617735
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.